Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Maia Biotechnology, Inc.

NYSE: MAIA · Life Sciences · 4 alerts · CIK 1878313

Share price
$1.01Close, Nov 16
Market cap
$62.4M
Shares outstanding
61.75MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Maia Biotechnology, Inc. filings on SEC EDGAR ↗

5:07 PM ET 10-Q
Financial Results

Maia Biotechnology Q3 2026 Results: Net Loss of $7.18M, Loss Narrows

For the nine months ended September 30, 2026, MAIA Biotechnology reported a net loss of $21.5 million, driven by $23.3 million in operating expenses. The company significantly strengthened its cash position to $21.3 million, up from $8.7 million at year-end 2025, primarily through a public offering that raised approximately $31.0 million.

Key figure
Net loss $7.18M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.